SMARCAL1 and glioblastoma: These findings contributed to the identification of novel glioblastoma subgroups, including a telomerase-positive subgroup driven by TERT-structural rearrangements (TERTSV) and an ALT-positive subgroup with mutations in ATRX or SMARCAL1 [19] (Figure 1A).